Follow the people · Insider
Jose Manuel Otero
Jose Manuel Otero files insider transactions with the SEC as a chief operating officer of Lexeo Therapeutics (LXEO). We hold 5 disclosed purchases and sales filed since 14 June 2024, 2 of them in the last 90 days.
- Files forLXEO
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 12 June 2024 — 18 August 2026Chief Operating Officer · Lexeo Therapeutics (LXEO)24 Form 4 lines · source: SEC Form 4
Everything they disclosed
24 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,304 shares of Lexeo TherapeuticsSEC Form 419 August 2026Common Stock · traded 18 August 2026 · filed 19 August 2026
- was granted 12,060 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 4,666 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- ▼ sold on the open market 1,302 shares of Lexeo TherapeuticsSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 5,930 shares of Lexeo TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- was granted 5,930 shares of Lexeo TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- ▼ sold on the open market 721 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 November 2025 · filed 20 February 2026
- ▼ sold on the open market 721 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 November 2025 · filed 20 February 2026
- ▼ sold on the open market 3,016 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 3,016 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- was granted 65,000 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- was granted 260,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 260,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 65,000 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- ▼ sold on the open market 721 shares of Lexeo TherapeuticsSEC Form 420 November 2025Common Stock · traded 18 August 2025 · filed 20 November 2025
- was granted 5,940 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 15 October 2025 · filed 17 October 2025
- ▼ sold on the open market 2,091 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 17 October 2025 · filed 17 October 2025
- ▼ sold on the open market 24 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 17 October 2025 · filed 17 October 2025
- ▼ sold on the open market 2,848 shares of Lexeo TherapeuticsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- was granted 5,720 shares of Lexeo TherapeuticsSEC Form 49 April 2025Common Stock · traded 14 March 2025 · filed 9 April 2025
- was granted 52,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 410 January 2025Stock Option (right to buy) · traded 7 January 2025 · filed 10 January 2025
- was granted 26,250 shares of Lexeo TherapeuticsSEC Form 410 January 2025Common Stock · traded 7 January 2025 · filed 10 January 2025
- was granted 187,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 414 June 2024Stock Option (Right to Buy) · traded 12 June 2024 · filed 14 June 2024
- was granted 31,250 shares of Lexeo TherapeuticsSEC Form 414 June 2024Common Stock · traded 12 June 2024 · filed 14 June 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.